NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD
3.0283
-0.29 (-8.79%)
The current stock price of SNES is 3.0283 USD. In the past month the price decreased by -1.04%. In the past year, price decreased by -65.87%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
PFE | PFIZER INC | 8.46 | 149.04B | ||
SNY | SANOFI-ADR | 13.62 | 136.54B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
ZTS | ZOETIS INC | 27.1 | 72.39B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Senestech Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Phoenix, Arizona and currently employs 25 full-time employees. The company went IPO on 2016-12-08. SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The firm has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The firm's technology can also be applied to other mammalian species.
SENESTECH INC
777 W. Pinnacle Peak Road, Suite B104
Phoenix ARIZONA 85027 US
CEO: Kenneth Siegel
Employees: 25
Company Website: https://senestech.com/
Investor Relations: https://senestech.investorroom.com/
Phone: 19287794143
The current stock price of SNES is 3.0283 USD. The price decreased by -8.79% in the last trading session.
The exchange symbol of SENESTECH INC is SNES and it is listed on the Nasdaq exchange.
SNES stock is listed on the Nasdaq exchange.
7 analysts have analysed SNES and the average price target is 10.2 USD. This implies a price increase of 236.82% is expected in the next year compared to the current price of 3.0283. Check the SENESTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SENESTECH INC (SNES) has a market capitalization of 3.12M USD. This makes SNES a Nano Cap stock.
SENESTECH INC (SNES) currently has 25 employees.
SENESTECH INC (SNES) has a support level at 2.96 and a resistance level at 3.1. Check the full technical report for a detailed analysis of SNES support and resistance levels.
The Revenue of SENESTECH INC (SNES) is expected to grow by 61.35% in the next year. Check the estimates tab for more information on the SNES EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SNES does not pay a dividend.
SENESTECH INC (SNES) will report earnings on 2025-05-07.
SENESTECH INC (SNES) does not have a PE ratio as the earnings reported over the last twelve months were negative (-17.78).
The outstanding short interest for SENESTECH INC (SNES) is 3.81% of its float. Check the ownership tab for more information on the SNES short interest.
ChartMill assigns a technical rating of 3 / 10 to SNES. When comparing the yearly performance of all stocks, SNES is a bad performer in the overall market: 82.89% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SNES. Both the profitability and financial health of SNES have multiple concerns.
Over the last trailing twelve months SNES reported a non-GAAP Earnings per Share(EPS) of -17.78. The EPS increased by 84.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -149.74% | ||
ROE | -182.47% | ||
Debt/Equity | 0.05 |
ChartMill assigns a Buy % Consensus number of 83% to SNES. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 96.61% and a revenue growth 61.35% for SNES